67 related articles for article (PubMed ID: 21446715)
1. Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.
Zhang F; Shao J; Tian J; Zhong Y; Ye L; Meng X; Liu Q; Wang H
Sci Rep; 2016 Apr; 6():24233. PubMed ID: 27052887
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile.
Zheng J; Zhou L; Gong X; Yang F; Cheng J; Ma R; Wu C; Xu Z; Zhu W; He Y; Shen J
Eur J Med Chem; 2024 Jun; 275():116564. PubMed ID: 38875810
[TBL] [Abstract][Full Text] [Related]
3. Overview of the structure and function of the dopamine transporter and its protein interactions.
Nepal B; Das S; Reith ME; Kortagere S
Front Physiol; 2023; 14():1150355. PubMed ID: 36935752
[TBL] [Abstract][Full Text] [Related]
4. Novel serotonin transporter regulators: Natural aristolane- and nardosinane- types of sesquiterpenoids from Nardostachys chinensis Batal.
Chen YP; Ying SS; Zheng HH; Liu YT; Wang ZP; Zhang H; Deng X; Wu YJ; Gao XM; Li TX; Zhu Y; Xu YT; Wu HH
Sci Rep; 2017 Nov; 7(1):15114. PubMed ID: 29118341
[TBL] [Abstract][Full Text] [Related]
5. Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?
Sharma H; Santra S; Dutta A
Future Med Chem; 2015; 7(17):2385-406. PubMed ID: 26619226
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.
Dutta AK; Santra S; Sharma H; Voshavar C; Xu L; Mabrouk O; Antonio T; Reith ME
PLoS One; 2014; 9(11):e113420. PubMed ID: 25427177
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitors.
Liu S; Zha C; Nacro K; Hu M; Cui W; Yang YL; Bhatt U; Sambandam A; Isherwood M; Yet L; Herr MT; Ebeltoft S; Hassler C; Fleming L; Pechulis AD; Payen-Fornicola A; Holman N; Milanowski D; Cotterill I; Mozhaev V; Khmelnitsky Y; Guzzo PR; Sargent BJ; Molino BF; Olson R; King D; Lelas S; Li YW; Johnson K; Molski T; Orie A; Ng A; Haskell R; Clarke W; Bertekap R; O'Connell J; Lodge N; Sinz M; Adams S; Zaczek R; Macor JE
ACS Med Chem Lett; 2014 Jul; 5(7):760-5. PubMed ID: 25050161
[TBL] [Abstract][Full Text] [Related]
8. Novel C-1 substituted cocaine analogs unlike cocaine or benztropine.
Reith ME; Ali S; Hashim A; Sheikh IS; Theddu N; Gaddiraju NV; Mehrotra S; Schmitt KC; Murray TF; Sershen H; Unterwald EM; Davis FA
J Pharmacol Exp Ther; 2012 Nov; 343(2):413-25. PubMed ID: 22895898
[TBL] [Abstract][Full Text] [Related]
9. The novel trisubstituted pyran derivative D-142 has triple monoamine reuptake inhibitory activity and exerts potent antidepressant-like activity in rodents.
Dutta AK; Gopishetty B; Gogoi S; Ali S; Zhen J; Reith M
Eur J Pharmacol; 2011 Dec; 671(1-3):39-44. PubMed ID: 21963455
[TBL] [Abstract][Full Text] [Related]
10. Triple reuptake inhibitors: a patent review (2006 - 2012).
Shao L; Li W; Xie Q; Yin H
Expert Opin Ther Pat; 2014 Feb; 24(2):131-54. PubMed ID: 24289044
[TBL] [Abstract][Full Text] [Related]
11. Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.
Skolnick P; Krieter P; Tizzano J; Basile A; Popik P; Czobor P; Lippa A
CNS Drug Rev; 2006; 12(2):123-34. PubMed ID: 16958986
[TBL] [Abstract][Full Text] [Related]
12. Further structure-activity relationship studies on 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: identification of compounds with triple uptake inhibitory activity as potential antidepressant agents.
Gopishetty B; Hazeldine S; Santra S; Johnson M; Modi G; Ali S; Zhen J; Reith M; Dutta A
J Med Chem; 2011 Apr; 54(8):2924-32. PubMed ID: 21446715
[TBL] [Abstract][Full Text] [Related]
13. Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.
Sharma H; Santra S; Debnath J; Antonio T; Reith M; Dutta A
Bioorg Med Chem; 2014 Jan; 22(1):311-24. PubMed ID: 24315194
[TBL] [Abstract][Full Text] [Related]
14. Structural exploration of (3S,6S)-6-benzhydryl-N-benzyltetrahydro-2H-pyran-3-amine analogues: identification of potent triple monoamine reuptake inhibitors as potential antidepressants.
Santra S; Gogoi S; Gopishetty B; Antonio T; Zhen J; Reith ME; Dutta AK
ChemMedChem; 2012 Dec; 7(12):2093-100. PubMed ID: 23060293
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
